The Record header image

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

September 2024

Select Medicare Advantage members will receive kidney health evaluation test kits from Everlywell in early September

Blue Cross Blue Shield of Michigan and Blue Care Network are partnering with Everlywell, an independent company, to distribute in-home test kits to select Medicare Advantage members with diabetes. If your patients receive an advance notice letter about the kits and have questions, encourage them to take advantage of this convenient, no-cost testing.

Kidney Health Evaluation for Patients with Diabetes is a Healthcare Effectiveness Data and Information Set® measure that evaluates the percentage of diabetic patients who received both a serum estimated glomerular filtration rate and a urine albumin creatinine ratio during the measurement year.

Members will receive eGFR kits or uACR kits, or both, depending on which aspect of the measure they’re considered to be noncompliant. If members are targeted for eGFR, their blood sample may also be tested for hemoglobin A1c, if needed.

Members will be encouraged to discuss test results with their primary care providers.   

Test result notification:

 

Normal results

Abnormal results

Medicare Plus Blue℠ or BCN Advantage℠ member

Mail

Mail and phone call;
certified letter if unable to reach

Primary care
provider

DirectTrust electronic-medical-record messaging or
fax (providers without a DirectTrust account)

HEDIS® is a registered trademark of the National Committee for Quality Assurance.

Everlywell is an independent company that distributes in-home test kits to select Medicare Advantage members with diabetes for Blue Cross Blue Shield of Michigan and Blue Care Network.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2023 American Medical Association. All rights reserved.